Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1929-2012Class I

Alere Triage Cardiac Panel PN 97000HS Used for the quantitative determination of creatine kinase MD (CK--MB)...

Alere San Diego, Inc. / initiated 2012-05-22 / Terminated / root cause: manufacturing process

Alere San Diego, Inc. began a recall of Alere Triage Cardiac Panel PN 97000HS Used for the quantitative determination of creatine kinase MD (CK--MB), myoglobin and troponin I in EDTA anticoagulated... on . FDA classified it as Class I and gives the reason as "Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1929-2012
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Alere San Diego, Inc.
Product
Alere Triage Cardiac Panel PN 97000HS Used for the quantitative determination of creatine kinase MD (CK--MB), myoglobin and troponin I in EDTA anticoagulated whole blood or plasma specimens.
Product code
NBC Test, Natriuretic Peptide
Reason for recall
Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Phase 1 of the recall included a recall communication being initiated on May 22, 2012 with Alere forwarding a recall letter to all their customers who purchased the Triage CardioProfiler Panel, Triage Cardiac Panel, Triage Profiler SOB Panel, Triage BNP, and Triage D-dimer. The letter informed the customers of the problems identified and the actions to be taken. Customers were instructed to discontinue use of the affected product, and to complete and fax the enclosed verification form within 10 days. Phase 2 of the recall included a recall communication letter being forwarded to customers on 6/11/12. The second letter included additional lots of Triage products that go beyond the lots included in an earlier recall notification letter. The letter informed the customers that the additional lots have significantly decreased precision relative to the package insert which could result in an increased frequency of false positive or false negative results. A third letter dated June 12, 2012 included 3 more lots for the Triage Cardio Profiler Panel PN 97100CP and Alere Triage Profiler SOB Panel PN 97300. The letter informed the customers that the additional lots have an increased frequency of Troponin I results >0.05 ng/mL for samples which are found to be below 0.05 ng/mL upon additional testing. Customers with questions about the information contained in the notifications, were instructed to contact Alere San Diego at (877) 308-8287 or at 9975 Summers Ridge Road, San Diego, CA 92121.
Quantity in commerce
6,044 kits
Distribution
Nationwide Distribution
Product codes and lots
Phase 1:  K50514B, W49753B, W49754B, W49756B, W49757B, W49758B, W49760B, W49761B, W49762B, W49764B, W49767B, W49768B, W49769B, W49770B, W50608B, W50613B, W50621B, W50623B, W50625B, W50632B, W50634B, W50637B, W50639B, W50641B, W50642B, W51114B, and W51119B.   Phase 2:  W49766B, W50605B, W50627B, W50628B, and W50629B.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1929-2012
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1928-2012Class ITerminatedVoluntary: Firm initiated
Z-1929-2012Class ITerminatedVoluntary: Firm initiated
Z-1930-2012Class ITerminatedVoluntary: Firm initiated
Z-1931-2012Class ITerminatedVoluntary: Firm initiated
Z-1932-2012Class ITerminatedVoluntary: Firm initiated